We are live on ! Find out more
DCP

Distillate Capital Partners Portfolio holdings

AUM $1.9B
1-Year Est. Return 2.22%
This Fund
S&P 500
This Quarter Est. Return
-5.86%
1 Year Est. Return
-2.22%
3 Year Est. Return
+17.78%
5 Year Est. Return
+50.1%
10 Year Est. Return
AUM
$2.04B
AUM Growth
+$39M
Cap. Flow
+$178M
Cap. Flow %
8.74%
Top 10 Hldgs %
22.14%
Holding
128
New
64
Increased
15
Reduced
39
Closed
10

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$49.2M
2
PG icon
Procter & Gamble
PG
+$43.1M
3
QCOM icon
Qualcomm
QCOM
+$35.9M
4
ADBE icon
Adobe
ADBE
+$35.2M
5
LOW icon
Lowe's Companies
LOW
+$30.9M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$77.6M
2
ABT icon
Abbott
ABT
+$62.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$55.1M
4
ADP icon
Automatic Data Processing
ADP
+$54.9M
5
CRM icon
Salesforce
CRM
+$36.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.45%
2 Technology 21.91%
3 Industrials 14.73%
4 Consumer Discretionary 13.62%
5 Consumer Staples 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIS icon
126
Fidelity National Information Services
FIS
$22.1B
-224,320
Closed -$18.8M
TXT icon
127
Textron
TXT
$15.1B
-378,146
Closed -$33.5M
ZM icon
128
Zoom
ZM
$29.7B
-223,666
Closed -$15.6M

Similar funds

Distillate Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Distillate Capital Partners held 128 positions worth $2.04B, up 2% from $2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Distillate Capital Partners deployed $178M of net new capital in Q4 2024, opening 64 new positions and adding to 15 existing holdings. Its largest new stake was T-Mobile US: 216,512 shares worth $47.8M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $55.1M trimmed.

  • Distillate Capital Partners's largest Q4 2024 buy was T-Mobile US: 216,512 shares worth $47.8M.
  • Distillate Capital Partners added most to UnitedHealth in Q4 2024, an estimated $13.4M increase.
  • Distillate Capital Partners's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $55.1M.
  • Distillate Capital Partners fully exited Amgen in Q4 2024, selling an estimated $77.6M.
  • Distillate Capital Partners's ten largest holdings make up 22% of its $2.04B portfolio in Q4 2024.
  • Distillate Capital Partners opened 64 new positions and closed 10 in Q4 2024.
  • Distillate Capital Partners's portfolio value rose 2% quarter-over-quarter to $2.04B.

Based on Distillate Capital Partners's 13F filing for Q4 2024, filed 13 Feb 2025.